Evidenced-based treatment of opioid-dependent patients (Q36628470)

15 August 2017

0 references

1 reference

title

Evidenced-based treatment of opioid-dependent patients (English)

1 reference

15 August 2017

Wim Van den Brink

1

1 reference

15 August 2017

Christian Haasen

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

Canadian Journal of Psychiatry

15 August 2017

1 reference

15 August 2017

51

1 reference

15 August 2017

10

1 reference

15 August 2017

635-646

1 reference

Opiate addiction in China: current situation and treatments

15 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Prescription opioid abuse in patients presenting for methadone maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

A 33-year follow-up of narcotics addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Addiction is a brain disease, and it matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

The neurobiology of opioid dependence: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Strategies for preventing heroin overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Heroin overdose: causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

21 January 2018

Acute heroin overdose

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Intravenous or intramuscular/subcutaneous naloxone in opioid overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Overdoses among friends: drug users are willing to administer naloxone to others

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Take-home naloxone to reduce heroin death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Bystander resuscitation attempts at heroin overdose: does it improve outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Receptor-selective changes in mu-, delta- and kappa-opioid receptors after chronic naltrexone treatment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Non-fatal overdose and subsequent drug treatment among injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

An abstinence-oriented program for substance use disorders: poorer outcome associated with opiate dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Combating opiate dependence: a comparison among the available pharmacological options

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Nimodipine in opiate detoxification: a controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Methadone tapering plus amantadine to detoxify heroin-dependent inpatients with or without an active cocaine use disorder: two randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Pharmacologic treatments for heroin and cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Abstinence-orientated buprenorphine replacement therapy for young adults in out-patient counselling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Management of drug and alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Evaluation of an injection depot formulation of buprenorphine: placebo comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

The place of detoxification in treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Dangers involved in rapid opioid detoxification while using opioid antagonists: dehydration and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Three methods of opioid detoxification in a primary care setting. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

General anaesthesia does not improve outcome in opioid antagonist detoxification treatment: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Ultrarapid opiate detoxification: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Efficacy of buspirone in the treatment of opioid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Treatment of opioid-dependent pregnant women with buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Opiate addiction in gravidity - consequences for the newborn. Results of an interdisciplinary treatment concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Obstetric and neonatal outcomes associated with maternal naltrexone exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Anticraving medications for relapse prevention: a possible new class of psychoactive medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

The efficacy of naltrexone in preventing reabuse of heroin after detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Rapid opioid detoxification in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Depot naltrexone: long-lasting antagonism of the effects of heroin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

A new approach to preventing relapse in opiate addicts: a psychometric evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

A pilot double blind placebo controlled trial of sertraline with naltrexone in the treatment of opiate dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Methods of detoxification and their role in treating patients with opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Relationship between LAAM-methadone preference and treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

A novel opioid maintenance program for prisoners: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Medication development for addictive disorders: the state of the science

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Long-term methadone maintenance effectiveness: psychosocial and pharmacological variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

The effects of psychosocial services in substance abuse treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

A randomized controlled trial of interim methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Changes in methadone treatment practices: results from a national panel study, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Torsade de pointes associated with very-high-dose methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Are supplementary services provided during methadone maintenance really cost-effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Treatment of heroin dependence with buprenorphine in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

A pilot study of primary-care-based buprenorphine maintenance for heroin dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Consensus statement on office-based treatment of opioid dependence using buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Effects of buprenorphine/naloxone in opioid-dependent humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

A critical appraisal of the Australian comparative trial of methadone and buprenorphine maintenance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Heroin-assisted treatment as a response to the public health problem of opiate dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

The Swiss heroin trials. Trial is needed comparing decriminalisation of heroin with existing policy of prohibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

The Swiss heroin trials: testing alternative approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

NAOMI--her time has come. North American Opiate Medication Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Maintenance treatment of opiate addicts in Germany with medications containing codeine--results of a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Use of slow-release oral morphine for the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Safety and efficacy of oral slow release morphine for maintenance treatment in heroin addicts: a 6-month open noncomparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Report of the Council on Scientific Affairs: methadone maintenance and needle-exchange programs to reduce the medical and public health consequences of drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

Safer injection facility use and syringe sharing in injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605101003

10.1177/070674370605101003

21 January 2018

Identifiers

DOI

0 references

1 reference